Benjamin L. Palleiko is the CEO of KalVista Pharmaceuticals, a biotech company focusing on innovative treatments. He stepped into this role on March 6, 2023, after serving as the President and Chief Financial Officer. His journey in the biotech scene...
Benjamin L. Palleiko is the CEO of KalVista Pharmaceuticals, a biotech company focusing on innovative treatments. He stepped into this role on March 6, 2023, after serving as the President and Chief Financial Officer. His journey in the biotech scene includes significant positions at Regal Healthcare and Ore Pharmaceutical Holdings, plus he co-founded Cielo Therapeutics, a private oncology company. An interesting part of his background is that he served as a Naval Aviator before shifting gears into finance and biotech. Palleiko holds a degree in Quantitative Economics from Tufts University and earned his MBA from the University of Chicago. In 2023, he earned $720,102 in total compensation, comprising a salary of $514,500 and a cash bonus, highlighting his strong performance in executing the company’s objectives. His vision for KalVista includes ambitious plans to further breakthrough therapies, showing his commitment to making a difference in the pharmaceutical industry.